Dionísio de Sousa, I.J.; Marques, D.S.; Príncipe, C.; Portugal, R.V.; Canberk, S.; Prazeres, H.; Lopes, J.M.; Gimba, E.R.P.; Lima, R.T.; Soares, P.
Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer. Diagnostics 2020, 10, 525.
https://doi.org/10.3390/diagnostics10080525
AMA Style
Dionísio de Sousa IJ, Marques DS, Príncipe C, Portugal RV, Canberk S, Prazeres H, Lopes JM, Gimba ERP, Lima RT, Soares P.
Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer. Diagnostics. 2020; 10(8):525.
https://doi.org/10.3390/diagnostics10080525
Chicago/Turabian Style
Dionísio de Sousa, Isabel J., Durval S. Marques, Catarina Príncipe, Raquel V. Portugal, Sule Canberk, Hugo Prazeres, José M. Lopes, Etel R. P. Gimba, Raquel T. Lima, and Paula Soares.
2020. "Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer" Diagnostics 10, no. 8: 525.
https://doi.org/10.3390/diagnostics10080525
APA Style
Dionísio de Sousa, I. J., Marques, D. S., Príncipe, C., Portugal, R. V., Canberk, S., Prazeres, H., Lopes, J. M., Gimba, E. R. P., Lima, R. T., & Soares, P.
(2020). Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer. Diagnostics, 10(8), 525.
https://doi.org/10.3390/diagnostics10080525